Skip to content
10-Q

Quarterly Report

ArtVentive Medical Group, Inc.

0001056520-16-000288

← back to feed
Filed
Aug 15, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 12, 2016 63.72M sh
Operating Cash Flow Q2 2016 · Jun 30, 2016 −$65.84K
Operating Cash Flow Q2 2016 · Jun 30, 2015 −$1.84M
Long Term Debt Q2 2016 · Jun 30, 2016 $500K
Long Term Debt Q2 2016 · Dec 31, 2015 $500K
Cash And Equivalents Q2 2016 · Jun 30, 2016 $5.94K
Cash And Equivalents Q2 2016 · Dec 31, 2015 $21.78K
Stockholders Equity Q2 2016 · Jun 30, 2016 −$2.06M
Stockholders Equity Q2 2016 · Dec 31, 2015 −$970.67K
Current Liabilities Q2 2016 · Jun 30, 2016 $1.65M
Current Liabilities Q2 2016 · Dec 31, 2015 $924.09K
Current Assets Q2 2016 · Jun 30, 2016 $65.8K
Current Assets Q2 2016 · Dec 31, 2015 $354.6K
Total Assets Q2 2016 · Jun 30, 2016 $86.38K
Total Assets Q2 2016 · Dec 31, 2015 $453.42K
Sga Expense Q2 2016 · Jun 30, 2016 $240.3K
Sga Expense Q2 2016 · Jun 30, 2016 $682.46K
Sga Expense restated Q2 2016 · Jun 30, 2015 $551.06K
Sga Expense restated Q2 2016 · Jun 30, 2015 $1.14M
Rd Expense Q2 2016 · Jun 30, 2016 $284.47K
Rd Expense Q2 2016 · Jun 30, 2016 $464.12K
Rd Expense Q2 2016 · Jun 30, 2015 $324.14K
Rd Expense Q2 2016 · Jun 30, 2015 $626.06K
Net Income Q2 2016 · Jun 30, 2016 −$526K
Net Income Q2 2016 · Jun 30, 2016 −$1.15M
Net Income Q2 2016 · Jun 30, 2015 −$876.49K
Net Income restated Q2 2016 · Jun 30, 2015 −$1.76M
Cost Of Revenue Q2 2016 · Jun 30, 2016 $19.13K
Cost Of Revenue Q2 2016 · Jun 30, 2016 $65.12K
Cost Of Revenue Q2 2016 · Jun 30, 2015 $94K
Cost Of Revenue Q2 2016 · Jun 30, 2015 $158.19K
Revenue Q2 2016 · Jun 30, 2016 $19.13K
Revenue Q2 2016 · Jun 30, 2016 $65.12K
Revenue Q2 2016 · Jun 30, 2015 $94K
Revenue Q2 2016 · Jun 30, 2015 $158.19K